Management of pseudomyxoma peritonei

被引:26
作者
Qu, Zhi-Bo [1 ]
Liu, Lian-Xin [1 ]
机构
[1] Harbin Med Coll, Clin Coll 1, Dept Gen Surg, Harbin 150001, Heilongjiang Pr, Peoples R China
关键词
pseudomyxoma peritonei; peritonectomy; hyperthermic intraperitoneal chemotherapy; Sugarbaker procedures;
D O I
10.3748/wjg.v12.i38.6124
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Pseudomyxoma peritonei (PMP) is a rare disease. It refers to a progressive disease process within the peritoneum which originates from the appendix or ovaries and is characterised by the production of copious amounts of mucinous fluid resulting in a "jelly belly". If untreated the condition is fatal. The traditional approach to PMP is based on repeated surgical debulking procedures, often associated with intraperitoneal or systemic chemotherapy. The natural history of this disease has been drastically modified since the introduction of a new surgical approach defined as a peritonectomy procedure. This paper is to review the literature on this treatment strategy. (C) 2006 The WJG Press. All rights reserved.
引用
收藏
页码:6124 / 6127
页数:4
相关论文
共 32 条
[1]  
[Anonymous], SURG ONCOL CLIN N AM
[2]   Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma [J].
Begossi, G ;
Gonzalez-Moreno, S ;
Ortega-Perez, G ;
Fon, LJ ;
Sugarbaker, PH .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2002, 28 (01) :80-87
[3]   Systematic review of the Sugarbaker procedure for pseudomyxoma peritonei [J].
Bryant, J ;
Clegg, AJ ;
Sidhu, MK ;
Brodin, H ;
Royle, P ;
Davidson, P .
BRITISH JOURNAL OF SURGERY, 2005, 92 (02) :153-158
[4]  
Bryant J, 2004, HEALTH TECHNOL ASSES, V8, P1
[5]  
Deraco M, 2003, Tumori, V89, P54
[6]   Peritonectiomy and intraperitoneal hyperthermic perfusion (IPHP): A strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei [J].
Deraco, M ;
Baratti, D ;
Inglese, MG ;
Allaria, B ;
Andreola, S ;
Gavazzi, C ;
Kusamura, S .
ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (04) :393-398
[7]   Feasibility of peritonectomy associated with intraperitoneal hyperthermic perfusion in patients with pseudomyxoma peritonei [J].
Deraco, M ;
Gronchi, A ;
Mazzaferro, V ;
Inglese, MG ;
Pennacchioli, E ;
Kusamura, S ;
Rizzi, M ;
Anselmi, RA ;
Vaglini, M .
TUMORI JOURNAL, 2002, 88 (05) :370-375
[8]   Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: A phase II clinical study [J].
Deraco, M ;
Rossi, CR ;
Pennacchioli, E ;
Guadagni, S ;
Somers, DC ;
Santoro, N ;
Raspagliesi, F ;
Kusamura, S ;
Vaglini, M .
TUMORI JOURNAL, 2001, 87 (03) :120-126
[9]  
Deraco M, 1999, TUMORI, V85, P1
[10]   Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy [J].
Feldman, AL ;
Libutti, SK ;
Pingpank, JF ;
Bartlett, DL ;
Beresnev, TH ;
Mavroukakis, SM ;
Steinberg, SM ;
Liewehr, DJ ;
Kleiner, DE ;
Alexander, HR .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4560-4567